40 results on '"Velásquez, Gustavo E."'
Search Results
2. Low detection rate of RT-PCR-confirmed COVID-19 using IgM/IgG rapid antibody tests in a large community sample in Lima, Peru
3. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis
4. Outcomes of a Career Development Program for Underrepresented Minority Investigators in the AIDS Clinical Trials Group
5. Experience with 4-month rifapentine and moxifloxacin-based tuberculosis treatment in San Francisco
6. Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
7. Experience With Four-Month Rifapentine and Moxifloxacin–Based Tuberculosis Treatment in San Francisco.
8. Recent advances in the treatment of tuberculosis
9. Respiratory, Cardiac, and Neuropsychiatric Manifestations of Postacute Sequelae of Coronavirus Disease 2019 in Lima, Peru
10. Promise and Peril of Pretomanid–Rifamycin Regimens for Drug-susceptible Tuberculosis
11. Additional file 1 of Low detection rate of RT-PCR-confirmed COVID-19 using IgM/IgG rapid antibody tests in a large community sample in Lima, Peru
12. Recent advances in the treatment of tuberculosis
13. Time From Infection to Disease and Infectiousness for Ebola Virus Disease, a Systematic Review
14. Clinical Outcomes of Individuals with COVID-19 and Tuberculosis during the Pre-Vaccination Period of the Pandemic: A Systematic Review
15. Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru
16. Disparities in SARS-CoV-2 Vaccination-to-Infection Risk During the COVID-19 Pandemic in Massachusetts
17. Prevalence of SARS-CoV-2 antibodies among market and city bus depot workers in Lima, Peru
18. Disparities in SARS-CoV-2 Vaccination-to-Infection Risk, Massachusetts 2020-2021
19. Disparities in SARS-CoV-2 Testing in Massachusetts During the COVID-19 Pandemic
20. SARS-CoV-2 Testing Disparities in Massachusetts
21. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies Among Market and City Bus Depot Workers in Lima, Peru.
22. Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series
23. Delayed Relapse of Paracoccidioidomycosis in the Central Nervous System: A Case Report
24. Quantitative assessment of the activity of antituberculosis drugs and regimens
25. Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
26. Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial
27. Making up the difference: ensuring the bioequivalence of fixed-dose combinations for tuberculosis
28. A Case of Disseminated Histoplasmosis in a Patient with Rheumatoid Arthritis on Abatacept
29. Erratum for Velásquez et al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis
30. Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts
31. Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis
32. Novel Ordered Stepped-Wedge Cluster Trial Designs for Detecting Ebola Vaccine Efficacy Using a Spatially Structured Mathematical Model
33. Impact of HIV on mortality among patients treated for tuberculosis in Lima, Peru: a prospective cohort study
34. Clinical Relevance of Routine Pyrazinamide Drug Susceptibility Testing in Multidrug-Resistant Tuberculosis
35. Impact of HIV on mortality among patients treated for tuberculosis in Lima, Peru: a prospective cohort study.
36. Scientific advances and the end of tuberculosis: a report from the LancetCommission on Tuberculosis
37. Reply to te Brake : Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
38. Percent of lung involved in disease on chest X-ray predicts unfavorable treatment outcome in pulmonary tuberculosis.
39. Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized, Controlled Clinical Trial.
40. SARS-CoV-2 Testing Disparities in Massachusetts.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.